Literature DB >> 12045687

Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok.

Dale J Hu1, Shambavi Subbarao, Suphak Vanichseni, Philip A Mock, Frits van Griensven, Robert Nelson, Lily Nguyen, Dwip Kitayaporn, Nancy L Young, Don Des Jarlais, Robert Byers, Kachit Choopanya, Timothy D Mastro.   

Abstract

We analyzed data from a prospective cohort study of injection drug users (IDUs) attending methadone treatment clinics in Bangkok, Thailand, during 1995-1998 to characterize factors associated with a period of high incidence (PHI) from July 1996 through January 1997 compared with periods of lower incidence. Sociobehavioral characteristics were similar for all participants during and outside the PHI except for the following: there was more reported drug injection while IDUs were incarcerated during the PHI (odds ratio, 1.67; p =.02) and significantly higher proportions of persons reported heroin injection (91% vs. 75%, respectively; p =.02) and higher frequencies of daily injection and sharing of injection equipment (40% vs. 25%, respectively; p =.05) during the PHI than outside the PHI. Through most of the first year after seroconversion, plasma HIV-1 loads were significantly higher in persons who seroconverted during the PHI than in those who seroconverted outside the PHI. Higher viral loads may potentially contribute to faster disease progression and increased infectiousness or transmissibility to subsequent contacts. Our findings suggest that prevention efforts to reduce the effective size and turnover within IDU sharing networks may have a significant impact on the epidemic by disrupting the rapid transmission of HIV-1 from recently infected, highly infectious individuals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045687     DOI: 10.1097/00042560-200206010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

Review 1.  The challenge of HIV-1 subtype diversity.

Authors:  Barbara S Taylor; Magdalena E Sobieszczyk; Francine E McCutchan; Scott M Hammer
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

2.  BRIEF - SYNOPSIS OF THE CURRENT EVIDENCE ON THE RISK OF HIV TRANSMISSION.

Authors:  D Paquette; A Demers; M Gale-Rowe; T Wong
Journal:  Can Commun Dis Rep       Date:  2013-11-29

Review 3.  Neighborhoods and HIV: a social ecological approach to prevention and care.

Authors:  Carl A Latkin; Danielle German; David Vlahov; Sandro Galea
Journal:  Am Psychol       Date:  2013 May-Jun

4.  Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users.

Authors:  Artur Ramos; Dale J Hu; Lily Nguyen; Kim-Oanh Phan; Suphak Vanichseni; Nattawan Promadej; Kachit Choopanya; Margaret Callahan; Nancy L Young; Janet McNicholl; Timothy D Mastro; Thomas M Folks; Shambavi Subbarao
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island.

Authors:  Jennifer A Mitty; Lauri B Bazerman; Kyra Selwyn; Curt G Beckwith; Nickolas D Zaller; Josiah D Rich
Journal:  AIDS Read       Date:  2008-12

6.  HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995-2012.

Authors:  Michael Martin; Suphak Vanichseni; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Punnee Pitisuttithum; Jaranit Kaewkungwal; Frits van Griensven; Janet M McNicholl; Jordan W Tappero; Timothy D Mastro; Somyot Kittimunkong; Kachit Choopanya
Journal:  EClinicalMedicine       Date:  2019-04-01

7.  Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.

Authors:  Chawin Sirinak; Wanitchaya Kittikraisak; Duangporn Pinjeesekikul; Pricha Charusuntonsri; Phinai Luanloed; La-ong Srisuwanvilai; Sriprapa Nateniyom; Somsak Akksilp; Sirirat Likanonsakul; Wanchai Sattayawuthipong; Channawong Burapat; Jay K Varma
Journal:  BMC Public Health       Date:  2008-07-18       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.